Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
sore injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site pain (Verbatim: sore injection site). The outcome of the injection site pain was resolved (duration 24 hrs). It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine. It was unknown if the company considered the injection site pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 24-FEB-2026 This case was reported by a patient via interactive digital media. The reporter stated that in his case, he had no side effects. He mentioned that he experienced only a sore injection site for 24 hours. The batch number was not provided, and we are unable to contact the reporter.